PC
BLFS icon

Pier Capital’s BioLife Solutions BLFS Stock Holding History

Pier Capital’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-172,156
Closed -$2.38M – 121
2023
Q3 		$2.38M Sell
172,156
-2,522
-1% -$39.7K 0.38% 92
2023
Q2 		$3.86M Sell
174,678
-2,263
-1% -$47.7K 0.55% 88
2023
Q1 		$3.85M Buy
176,941
+20,953
+13% +$471K 0.58% 85
2022
Q4 		$2.84M Sell
155,988
-120,746
-44% -$2.49M 0.46% 89
2022
Q3 		$6.3M Buy
276,734
+945
+0.3% +$20.2K 1.08% 51
2022
Q2 		$3.81M Buy
275,789
+58,381
+27% +$857K 0.65% 74
2022
Q1 		$4.94M Buy
217,408
+75,066
+53% +$1.98M 0.63% 79
2021
Q4 		$5.3M Sell
142,342
-534
-0.4% -$22.9K 0.56% 87
2021
Q3 		$6.05M Sell
142,876
-2,269
-2% -$109K 0.63% 85
2021
Q2 		$6.46M Sell
145,145
-17,703
-11% -$624K 0.65% 90
2021
Q1 		$5.86M Buy
162,848
+14,761
+10% +$584K 0.56% 93
2020
Q4 		$5.91M Buy
+148,087
New +$5.05M 0.63% 88

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pier Capital's BLFS Position: Q4 2023 in Review

Pier Capital sold out of BioLife Solutions (BLFS) in Q4 2023, closing a stake of 172,156 shares — an estimated $2.38M sold.

Pier Capital first reported a position in BLFS in Q4 2020 and held it in 12 quarters. The position peaked at $6.46M in Q2 2021. 140 funds tracked by Wall St. Rank hold BLFS as of Q4 2023.

  • Pier Capital reported no remaining BioLife Solutions position as of Q4 2023 after selling out during the quarter.
  • Pier Capital sold 172,156 BioLife Solutions shares in Q4 2023, an estimated $2.38M.
  • Pier Capital first reported a position in BioLife Solutions in Q4 2020 and held it in 12 quarters.
  • Pier Capital's BioLife Solutions position peaked at $6.46M in Q2 2021.
  • 140 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2023.

Based on Pier Capital's 13F filing for Q4 2023, filed 15 Feb 2024.